Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Tigermed Reports 2020 Annual Results With Solid Growth 2021-03-29 21:21
Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company 2021-03-29 17:43
Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate 2021-03-29 16:07
HOYA Confirm the Long Term Technical Collaboration and Supply Agreement Related to Endoscopic Ultrasound Systems 2021-03-29 16:00
Jacobio Pharma Announces CNY486 Million Revenue for 2020 Annual Results 2021-03-29 13:11
Navigating China's Medical Technology, Regulations, Quality, and Future; Hundreds of Experts Gathered at On-site Conferences of Medtec China 2021-03-29 09:30
Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint 2021-03-29 08:27
Making Most out of Launched Products Fueling Diversified Innovation through Integrated Platform 2021-03-28 11:16
Foresee Pharmaceuticals Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025 for Treatment of COVID-19 Associated ARDS 2021-03-28 11:04
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results 2021-03-27 05:00
Genscript Biotech Reports Full Year 2020 Financial Results 2021-03-27 02:16
Modern Chinese Medicine Announces Year 2020 Annual Results 2021-03-26 22:08
Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years 2021-03-26 21:31
Kintor Pharmaceutical Limited Announces 2020 Business Progress and Annual Results 2021-03-26 20:54
InnoCare Releases 2020 Annual Results and Business Highlights 2021-03-26 19:39
Artificial Joint Surgical Robot, CUVIS-joint developed by CUREXO Receives EEA CE Marking 2021-03-26 17:00
Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2021-03-26 16:00
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115 2021-03-26 08:38
Antengene Announces Financial Results for Full Year 2020 2021-03-26 08:00
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion 2021-03-26 08:00
1 410 411 412 413 414 896